Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy.

ABSTRACT:

Objective

To determine how physicians approach pharmacologic dystonia treatment in people with CP and assess physician readiness to participate in a randomized trial comparing existing pharmacologic dystonia treatments.

Methods

We administered a REDCap survey to physician members of the American Academy of Cerebral Palsy and Developmental Medicine and of the Child Neurology Society to assess which pharmacologic agents they use to treat dystonia in CP and their preferred indications and dosing.

Results

Of 479 physicians surveyed, 240 (50%) responded. Respondents treated functionally limiting (95%) and generalized (57%) dystonia and most commonly used six medications: baclofen (95%), trihexyphenidyl (79%), gabapentin (67%), carbidopa/levodopa (55%), clonazepam (55%), an

SUBMITTER: Lott E 

PROVIDER: S-EPMC10862996 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature